Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trial.

Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trial. Am Heart J. 2003 Nov; 146(5):804-10.

View in: PubMed

subject areas

Aged
Counterpulsation
Female
Humans
Intra-Aortic Balloon Pumping
Male
Middle Aged
Myocardial Infarction
Myocardial Revascularization
Proportional Hazards Models
Shock, Cardiogenic
Survival Rate
Thrombolytic Therapy